Received: 2 March 2020
Accepted: 1 May 2020
First Online: 15 May 2020
Ethics approval and consent to participate
: The study protocol received prior approval from the University of Bath research ethics service (REACH EP 18/19 040) as well as the IMACS Scientific Committee, and all respondents provided informed consent.
: Not applicable
: M. Kuwana holds a patent on an anti-MDA5 antibody measuring system. JP has undertaken consultancy work for Actelion pharmaceuticals, Boehringer Ingelheim, and Sojournix Pharma outside of the submitted work. The remaining authors declare that they have no competing interests.